More recently GA was found to show a positive effect in the A17 mouse model of OPMD (expression of PABPN1-17ala in skeletal muscles [32]), improving muscle strength and decreasing PABPN1 aggregation [52]. The gene discussed is PABPN1; the disease is oculopharyngeal muscular dystrophy.